LIN9 anticorps (AA 5-103)
Aperçu rapide pour LIN9 anticorps (AA 5-103) (ABIN7165762)
Antigène
Voir toutes LIN9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 5-103
-
Réactivité croisée
- Humain
-
Purification
- >95%, Protein G purified
-
Immunogène
- Recombinant Human Protein lin-9 homolog protein (5-103AA)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Recommended dilution: IHC:1:500-1:1000,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- LIN9 (Lin-9 Homolog (LIN9))
-
Autre désignation
- LIN9
-
Sujet
-
Background: Acts as a tumor suppressor. Inhibits DNA synthesis. Its ability to inhibit oncogenic transformation is mediated through its association with RB1. Plays a role in the expression of genes required for the G1/S transition.
Aliases: BARA antibody, Beta subunit-associated regulator of apoptosis antibody, Beta-subunit associated regulator of apoptosis antibody, hLin-9 antibody, huLin-9 antibody, lin-9 antibody, lin9 antibody, LIN9_HUMAN antibody, pRB-associated protein antibody, Protein lin-9 homolog antibody, TGS antibody, TUDOR gene similar protein antibody, Type I interferon receptor beta chain-associated protein antibody
-
UniProt
- Q5TKA1
-
Pathways
- Cycle Cellulaire, Mitotic G1-G1/S Phases
Antigène
-